{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:27:26Z","timestamp":1791214046971,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Inclusion body myositis (IBM) is a slowly progressive inflammatory myopathy of the elderly that does not show significant clinical improvement in response to steroid therapy. Distinguishing IBM from polymyositis (PM) is clinically important since PM is steroid-responsive; however, the two conditions can show substantial histologic overlap.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We performed quantitative immunohistochemistry for (1) autophagic markers LC3 and p62 and (2) protein aggregation marker TDP-43 in 53 subjects with pathologically diagnosed PM, IBM, and two intermediate T cell-mediated inflammatory myopathies (polymyositis with COX-negative fibers and possible IBM). The percentage of stained fibers was significantly higher in IBM than PM for all three immunostains, but the markers varied in sensitivity and specificity. In particular, both LC3 and p62 were sensitive markers of IBM, but the tradeoff between sensitivity and specificity was smaller (and diagnostic utility thus greater) for LC3 than for p62. In contrast, TDP-43 immunopositivity was highly specific for IBM, but the sensitivity of this test was low, with definitive staining present in just 67% of IBM cases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>To differentiate IBM from PM, we thus recommend using a panel of LC3 and TDP-43 antibodies: the finding of &lt;14% LC3-positive fibers helps exclude IBM, while &gt;7% of TDP-43-positive fibers strongly supports a diagnosis of IBM. These data provide support for the hypothesis that disruption of autophagy and protein aggregation contribute to IBM pathogenesis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/2051-5960-1-29","type":"journal-article","created":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T12:15:16Z","timestamp":1372680916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies"],"prefix":"10.1186","volume":"1","author":[{"given":"Annie","family":"Hiniker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianne H","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han S","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Margeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,1]]},"reference":[{"key":"28_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/ncpneuro0261","volume":"2","author":"MC Dalakas","year":"2006","unstructured":"Dalakas MC: Sporadic inclusion body myositis\u2013diagnosis, pathogenesis and therapeutic strategies. Nat Clin Pract Neurol 2006, 2: 437\u2013447. 10.1038\/ncpneuro0261","journal-title":"Nat Clin Pract Neurol"},{"key":"28_CR2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1365-2990.2010.01153.x","volume":"37","author":"MC Dalakas","year":"2011","unstructured":"Dalakas MC: Review: An update on inflammatory and autoimmune myopathies. Neuropathol Appl Neurobiol 2011, 37: 226\u2013242. 10.1111\/j.1365-2990.2010.01153.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"28_CR3","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/BOR.0b013e32834b53cc","volume":"23","author":"SA Greenberg","year":"2011","unstructured":"Greenberg SA: Inclusion body myositis. Curr Opin Rheumatol 2011, 23: 574\u2013578. 10.1097\/BOR.0b013e32834b53cc","journal-title":"Curr Opin Rheumatol"},{"key":"28_CR4","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/NEN.0b013e31826183c8","volume":"71","author":"V Askanas","year":"2012","unstructured":"Askanas V, Engel WK, Nogalska A: Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis. J Neuropathol Exp Neurol 2012, 71: 680\u2013693. 10.1097\/NEN.0b013e31826183c8","journal-title":"J Neuropathol Exp Neurol"},{"key":"28_CR5","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/BOR.0b013e328313644c","volume":"20","author":"MJ Garlepp","year":"2008","unstructured":"Garlepp MJ, Mastaglia FL: Inclusion body myositis: new insights into pathogenesis. Curr Opin Rheumatol 2008, 20: 662\u2013668. 10.1097\/BOR.0b013e328313644c","journal-title":"Curr Opin Rheumatol"},{"key":"28_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/ana.21622","volume":"65","author":"G Karpati","year":"2009","unstructured":"Karpati G, O'Ferrall EK: Sporadic inclusion body myositis: pathogenic considerations. Ann Neurol 2009, 65: 7\u201311. 10.1002\/ana.21622","journal-title":"Ann Neurol"},{"key":"28_CR7","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/WCO.0b013e32833d3897","volume":"23","author":"CC Weihl","year":"2010","unstructured":"Weihl CC, Pestronk A: Sporadic inclusion body myositis: possible pathogenesis inferred from biomarkers. Curr Opin Neurol 2010, 23: 482\u2013488. 10.1097\/WCO.0b013e32833d3897","journal-title":"Curr Opin Neurol"},{"key":"28_CR8","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1212\/01.wnl.0000277527.69388.fe","volume":"70","author":"N Chahin","year":"2008","unstructured":"Chahin N, Engel AG: Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Neurology 2008, 70: 418\u2013424. 10.1212\/01.wnl.0000277527.69388.fe","journal-title":"Neurology"},{"key":"28_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ana.410390318","volume":"39","author":"V Askanas","year":"1996","unstructured":"Askanas V, Alvarez RB, Mirabella M, Engel WK: Use of anti-neurofilament antibody to identify paired-helical filaments in inclusion-body myositis. Ann Neurol 1996, 39: 389\u2013391. 10.1002\/ana.410390318","journal-title":"Ann Neurol"},{"key":"28_CR10","first-page":"103","volume":"30","author":"O Dubourg","year":"2011","unstructured":"Dubourg O, Wanschitz J, Maisonobe T, et al.: Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis. Acta Myol 2011, 30: 103\u2013108.","journal-title":"Acta Myol"},{"key":"28_CR11","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1097\/00005072-199607000-00003","volume":"55","author":"M Mirabella","year":"1996","unstructured":"Mirabella M, Alvarez RB, Bilak M, Engel WK, Askanas V: Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies. J Neuropathol Exp Neurol 1996, 55: 774\u2013786. 10.1097\/00005072-199607000-00003","journal-title":"J Neuropathol Exp Neurol"},{"key":"28_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jns.2008.11.010","volume":"278","author":"P Temiz","year":"2009","unstructured":"Temiz P, Weihl CC, Pestronk A: Inflammatory myopathies with mitochondrial pathology and protein aggregates. J Neurol Sci 2009, 278: 25\u201329. 10.1016\/j.jns.2008.11.010","journal-title":"J Neurol Sci"},{"key":"28_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0960-8966(00)00219-4","volume":"11","author":"MF van der Meulen","year":"2001","unstructured":"van der Meulen MF, Hoogendijk JE, Moons KG, Veldman H, Badrising UA, Wokke JH: Rimmed vacuoles and the added value of SMI-31 staining in diagnosing sporadic inclusion body myositis. Neuromuscul Disord 2001, 11: 447\u2013451. 10.1016\/S0960-8966(00)00219-4","journal-title":"Neuromuscul Disord"},{"key":"28_CR14","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/jnnp.2007.131334","volume":"79","author":"CC Weihl","year":"2008","unstructured":"Weihl CC, Temiz P, Miller SE, et al.: TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry 2008, 79: 1186\u20131189. 10.1136\/jnnp.2007.131334","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"28_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2990.2010.01108.x","volume":"37","author":"C D'Agostino","year":"2011","unstructured":"D'Agostino C, Nogalska A, Engel WK, Askanas V: In sporadic inclusion body myositis muscle fibres TDP-43-positive inclusions are less frequent and robust than p62 inclusions, and are not associated with paired helical filaments. Neuropathol Appl Neurobiol 2011, 37: 315\u2013320. 10.1111\/j.1365-2990.2010.01108.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"28_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/mus.21386","volume":"40","author":"M Salajegheh","year":"2009","unstructured":"Salajegheh M, Pinkus JL, Taylor JP, et al.: Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis. Muscle Nerve 2009, 40: 19\u201331. 10.1002\/mus.21386","journal-title":"Muscle Nerve"},{"key":"28_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/oxfordjournals.jbchem.a003147","volume":"131","author":"T Suzuki","year":"2002","unstructured":"Suzuki T, Nakagawa M, Yoshikawa A, et al.: The first molecular evidence that autophagy relates rimmed vacuole formation in chloroquine myopathy. J Biochem 2002, 131: 647\u2013651. 10.1093\/oxfordjournals.jbchem.a003147","journal-title":"J Biochem"},{"key":"28_CR18","doi-asserted-by":"publisher","first-page":"e36221","DOI":"10.1371\/journal.pone.0036221","volume":"7","author":"HS Lee","year":"2012","unstructured":"Lee HS, Daniels BH, Salas E, Bollen AW, Debnath J, Margeta M: Clinical utility of LC3 and p62 immunohistochemistry in diagnosis of drug-induced autophagic vacuolar myopathies: a case\u2013control study. PLoS One 2012, 7: e36221. 10.1371\/journal.pone.0036221","journal-title":"PLoS One"},{"key":"28_CR19","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.2353\/ajpath.2010.100050","volume":"177","author":"A Nogalska","year":"2010","unstructured":"Nogalska A, D'Agostino C, Terracciano C, Engel WK, Askanas V: Impaired autophagy in sporadic inclusion-body myositis and in endoplasmic reticulum stress-provoked cultured human muscle fibers. Am J Pathol 2010, 177: 1377\u20131387. 10.2353\/ajpath.2010.100050","journal-title":"Am J Pathol"},{"key":"28_CR20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00401-009-0564-6","volume":"118","author":"A Nogalska","year":"2009","unstructured":"Nogalska A, Terracciano C, D'Agostino C, King Engel W, Askanas V: p62\/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis. Acta Neuropathol 2009, 118: 407\u2013413. 10.1007\/s00401-009-0564-6","journal-title":"Acta Neuropathol"},{"key":"28_CR21","doi-asserted-by":"publisher","first-page":"C776","DOI":"10.1152\/ajpcell.00507.2009","volume":"298","author":"M Mehrpour","year":"2010","unstructured":"Mehrpour M, Esclatine A, Beau I, Codogno P: Autophagy in health and disease. 1. Regulation and significance of autophagy: an overview. Am J Physiol Cell Physiol 2010, 298: C776-C785. 10.1152\/ajpcell.00507.2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"28_CR22","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1097\/PAS.0b013e3182863fa8","volume":"37","author":"BH Daniels","year":"2013","unstructured":"Daniels BH, McComb RD, Mobley BC, Gultekin SH, Lee HS, Margeta M: LC3 and p62 as diagnostic markers of drug-induced autophagic vacuolar cardiomyopathy: a study of three cases. Am J Surg Pathol 2013, 37: 1014\u20131021. 10.1097\/PAS.0b013e3182863fa8","journal-title":"Am J Surg Pathol"},{"key":"28_CR23","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1212\/WNL.55.9.1385","volume":"55","author":"UA Badrising","year":"2000","unstructured":"Badrising UA, Maat-Schieman M, van Duinen SG, et al.: Epidemiology of inclusion body myositis in the Netherlands: a nationwide study. Neurology 2000, 55: 1385\u20131387. 10.1212\/WNL.55.9.1385","journal-title":"Neurology"},{"issue":"Pt 1","key":"28_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/brain\/120.1.39","volume":"120","author":"G Blume","year":"1997","unstructured":"Blume G, Pestronk A, Frank B, Johns DR: Polymyositis with cytochrome oxidase negative muscle fibres. Early quadriceps weakness and poor response to immunosuppressive therapy. Brain 1997,120(Pt 1):39\u201345.","journal-title":"Brain"},{"key":"28_CR25","unstructured":"Girolamo F, Lia A, Amati A, et al.: Overexpression of autophagic proteins in the skeletal muscle of sporadic inclusion body myositis. NeuropatholApplNeurobiol 10.1111\/nan.12040"},{"key":"28_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4161\/auto.5338","volume":"4","author":"DJ Klionsky","year":"2008","unstructured":"Klionsky DJ, Abeliovich H, Agostinis P, et al.: Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008, 4: 151\u2013175.","journal-title":"Autophagy"},{"key":"28_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00401-008-0471-2","volume":"117","author":"B Kusters","year":"2009","unstructured":"Kusters B, van Hoeve BJ, Schelhaas HJ, TerLaak H, van Engelen BG, Lammens M: TDP-43 accumulation is common in myopathies with rimmed vacuoles. Acta Neuropathol 2009, 117: 209\u2013211. 10.1007\/s00401-008-0471-2","journal-title":"Acta Neuropathol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-1-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:37:12Z","timestamp":1630543032000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/2051-5960-1-29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["28"],"URL":"https:\/\/doi.org\/10.1186\/2051-5960-1-29","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,1]]},"assertion":[{"value":"17 June 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"29"}}